NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000664

Registered date:02/04/2007

Supplemental Benefit of ARB in Maintenance of Sinus Rhythm after Left Atrial Ablation in Atrial Fibrillation using Valsartan

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedAtrial Fibrillation
Date of first enrollment2007/04/01
Target sample size180
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Valsartan40-80mg daily, during the study period. Control

Outcome(s)

Primary OutcomeA composite of all - reverse remodeling of left atrium and recurrence of atrial fibrillation.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum30years-old
Age maximum70years-old
GenderMale and Female
Include criteria
Exclude criteria(1)Patients who have renal dysfunction (serum creatinine>=3.0mg/dL or those who are receiving chronic hemodialysis (2) History of drug hypersensitivity to angiotensine II receptor blocker. (3)Patients who have severe liver dysfunction (4)Patents with cerebrovasucular disease (5)History of angioedema (6)History of malignant tumor or life threatening illness of poor prognosis (7)Pregnant or possibly pregnant patients (8)Patents after Cardiovascular surgery (9)Other patients deemed unsuitable as subjects of the study by the treating physician

Related Information

Contact

public contact
Name Koji Kumagai
Address 1-1 Seiryou-machi, Sendai-city Japan
Telephone
E-mail
Affiliation Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine
scientific contact
Name Hiroaki Shimokawa
Address 1-1 Seiryou-machi, Sendai-city Japan
Telephone 022(717)7153
E-mail
Affiliation Tohoku University Graduate School of Medicine Department of Cardiovascular Medicine